Literature DB >> 31305887

Plasma Neurofilament Light Chain Levels Are Associated With Cortical Hypometabolism in Alzheimer Disease Signature Regions.

Mahsa Mayeli1, Seyed Mohammad Mirshahvalad2, Vajiheh Aghamollaii2, Abbas Tafakhori2, Amirhussein Abdolalizadeh3, Farzaneh Rahmani3,4.   

Abstract

Neurofilament light chain (NFL) has been recently introduced as a biomarker of early dementia. 18-Fluorodeoxyglucose positron emission tomography (18F-FDG-PET) is a proxy for regional hypometabolism in Alzheimer disease (AD). Globally normalized 18F-FDG-PET values and levels of NFL and tau were obtained from 149 patients with mild cognitive impairment (MCI) from the baseline cohort of the Alzheimer's Disease Neuroimaging Initiative database. We adopted a stepwise partial correlation model using plasma NFL, plasma tau, CSF NFL, and regional cerebral metabolic rate of glucose (CMRGlc) as main variables, and age, sex, and Alzheimer's Disease Rating Scale (ADAS) as covariates. Significant regions were entered into a stepwise multiple regression analysis to investigate the independent correlation of each biomarker to baseline regional CMRGlc and its progression in patients with MCI. Higher baseline CSF NFL levels correlated with hypometabolism in bilateral precuneal and posterior cingulate cortex. After correction for age, sex, and ADAS score, plasma NFL levels correlated with hypometabolism in bilateral parahippocampal and middle temporal gyri. Cortical hypometabolism in bilateral parahippocampal gyri and right fusiform and middle temporal gyri was independently predicted by higher baseline plasma NFL levels in a multiple regression model. Plasma NFL promises to be an early biomarker of cortical hypometabolism in MCI and for MCI progression to AD.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Neurofilament light chain; Positron emission tomography; Tau

Year:  2019        PMID: 31305887     DOI: 10.1093/jnen/nlz054

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Plasma neurofilament light chain: A biomarker predicting severity in patients with acute ischemic stroke.

Authors:  Jixia Wu; Daqing Wu; Youbao Liang; Zhen Zhang; Lei Zhuang; Zhaoping Wang
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

2.  Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke.

Authors:  Peng Wang; Jia Fan; Ling Yuan; Yi Nan; Shanji Nan
Journal:  Neurotox Res       Date:  2020-01-02       Impact factor: 3.911

3.  Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.

Authors:  Edmarie Guzmán-Vélez; Henrik Zetterberg; Joshua T Fox-Fuller; Clara Vila-Castelar; Justin S Sanchez; Ana Baena; Gloria Garcia-Ospina; David Aguillon; Enmanuelle Pardilla-Delgado; Jennifer R Gatchel; Reisa A Sperling; Keith Johnson; Eric M Reiman; Kaj Blennow; Francisco Lopera; Yakeel T Quiroz
Journal:  Alzheimers Dement       Date:  2021-02-01       Impact factor: 21.566

4.  The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Xavier O Scott; Marisa E Stephens; Marie C Desir; W Dalton Dietrich; Robert W Keane; Juan Pablo de Rivero Vaccari
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 5.  Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer's Disease.

Authors:  Bin Zhou; Masanori Fukushima
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

6.  Plasma tau predicts cerebral vulnerability in aging.

Authors:  Jose L Cantero; Mercedes Atienza; Jaime Ramos-Cejudo; Silvia Fossati; Thomas Wisniewski; Ricardo S Osorio
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

7.  A Systematic Review of the Association between Amyloid-β and τ Pathology with Functional Connectivity Alterations in the Alzheimer Dementia Spectrum Utilizing PET Scan and rsfMRI.

Authors:  Seyede Anis Hasani; Mahsa Mayeli; Mohammad Amin Salehi; Rezvan Barzegar Parizi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.